#NephJCKidneys #KidneyWk On behalf of our Visual Abstract Team of @ASNKidney Portfolio of Journals, I would like to thank 🙏🏼 our Editors in Chief: @rajmehrotra1122, @ConnieMRhee, and @MikeAllonK360; Associate Director of Publications Shari Leventhal; Managing Editors: Natalie

@NephMadness @MonteNephrology @millymoons We got into the madness fever! We partied, we feasted 🍕and most importantly selected the best from each region and we got our champion!!! Let the best “team” win!!

There is a speed limit to correcting hyponatremia #Nephmadness 2⃣🏀2⃣4⃣ #Nephpearls 👉 https://t.co/g8sNOFiKGZ 👉 https://t.co/TsNpgzifDU

Check out the latest @BookBurton Podcasts 🎧 covering Chapter 14: Hypovolemic states #Nephpearls 👉🏼 Part 1 https://t.co/TTISTphlHq 👉🏼 Part 2 📢 20th Podcast https://t.co/eeYwJ9vABU

Complement-inhibiting drugs for the treatment of kidney diseases https://t.co/zJovgYRq7w

Potential origins of obesity-related glomerular hyperfiltration https://t.co/CQCkDBd8gS

From the AJKD archive (July 2009): Thirty-six Hippocratic Aphorisms of Nephrologic Interest https://t.co/8vg61Vhg78 (FREE) "We must look to the urinary evacuations, whether they resemble those of persons in health...."

Novel mechanisms of salt-sensitive #hypertension https://t.co/mmXjtarC3r @UvA_Amsterdam @MonashUni @UTokyo_News_en @ErasmusMC #KIMinireview #OpenAccess #ckd #inflammation #salt #diabeticnephropathy

Optimization of RAASi Therapy Toolkit 📌 Monitor and manage hyperkalemia and acute changes in kidney function related to RAASi #Nephpearls #Cardiorenal 👉🏼 https://t.co/2qRpZmP9qj

Beautiful tribute from prior fellows to Dr. Melamed @MelamedMichal, who served as our Fellowship Director (2013-2023). Dr. Melamed will continue to lead and inspire trainees and junior faculty @EinsteinMed @MonteNephrology. Thank you, Dr. Melamed! https://t.co/WOKnCcUk5e

@MonteNephrology family celebrating Class of 2023! @MelamedMichal @EinsteinMed

Kidney involvement in malaria https://t.co/fCFEApjT3N

.@goKDIGO is updating the 2021 Glomerular Diseases (GD) Guideline on an ongoing, chapter-by-chapter basis 📢 The KDIGO 2023 ANCA Guideline Update is now available for public review We invite you to review the guideline chapter update #Nephpearls  👉🏼 https://t.co/kQLRf4hwvU

Etiologies of #hyperkalemia https://t.co/BTMO5NqaDX True hyperK: 1. ↔️ Cellular shift 2. ⬇️ urinary excretion 3. ⬆️ production #Nephrology #FOAMed #MedEd

An approach to #polyuria (>3L urine/24 hours) Step 1: Solute 🍭 diuresis vs 💦 diuresis (low urine osm)? https://t.co/4ShzEt14hS #Nephrology #FOAMed #MedEd

Management of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) w/ glomerulonephritis as proposed by the @ACRheum 2021, @eular_org org 2022 & @goKDIGO 2021 Guidelines/ Recommendations ca. 2023 #Nephpearls 👉🏼 https://t.co/r4jbXhSVFp

A sample from the pathology teaching slide set on Anti-GBM antibody glomerulonephritis, jointly prepared by Arkana Laboratories and @goKDIGO #NephTwitter https://t.co/KwXMfV3VIP

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis (AAV) and relapsing disease: an international randomised controlled trial ca. 2023 #Nephpearls #NephJC #VisualAbstract by @Nikitap159 👉 https://t.co/pKgrGAor8T

Algorithmic Approach to Management of Patients With ANCA-Related Glomerulonephritis from @goKDIGO #Nephpearls #NephJC https://t.co/u5yEmKd1hE

Guide to #AKI & AKI in the #KidneyTransplant https://t.co/dPA2rDCHnN 🦀🦀🦀 C: NI toxicity + cancer 💊 R: ecurrence/rejection ⚡️ A: natomical (e.g. GU, transplant renal artery stenosis) B: K virus & other 🦠 #FOAMed #Nephrology #IM2023